This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of AbbVie Inc. (ABBV) slid 1.83% to $223.07 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&amp;P 500 Index rising 0.30% to 7,405.73 and the Dow Jones Industrial Average falling 0.16% to 50,786.01.
The stock's fall snapped a four-day winning streak.
AbbVie Inc. closed 8.88% below its 52-week high of $244.81, which the company achieved on October 1st.
The stock underperformed when compared to some of its competitors Monday, as Johnson &amp; Johnson (JNJ) fell 0.26% to $232.16, Pfizer Inc. (PFE) fell 1.61% to $25.62, and Amgen Inc. (AMGN) fell 1.10% to $345.73.
Trading volume (4.8 M) remained 1.4 million below its 50-day average volume of 6.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled June 8, 2026.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
06-08-26 1631ET

ABBV

AbbVie Inc. (ABBV) shares fell 1.83% to $223.07 on Monday, snapping a four-day winning streak and underperforming competitors like Johnson & Johnson, Pfizer, and Amgen. The decline occurred during a mixed market session where the S&P 500 rose slightly while the Dow Jones dipped. AbbVie closed 8.88% below its 52-week high of $244.81 set in October. Trading volume was lower than the 50-day average.

AbbVie Inc. Stock Underperforms Monday When Compared To Competitors